Point72 Asset Management
JNCE

Point72 Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Point72 Asset Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$701K Buy
2022
Q2 		$893K Buy
2022
Q1 		$1.93M Buy
2021
Q4 		$2.12M Buy
2020
Q1 		– Sell
2019
Q4 		$1.75M Buy